Replies to post #61945 on CWRUObserver.com -Financial News and Headlines -

[sublime]

ATRC 8.56 AtriCure to Present at C. E. Unterberg, Towbin Emerging Growth Opportunities Conference
Jul 3, 2007 8:30:00 AM

WEST CHESTER, Ohio, July 3 /PRNewswire-FirstCall/ -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company focused on developing, manufacturing and selling innovative surgical devices, announced today that David J. Drachman, President and Chief Executive Officer, is scheduled to present at the C. E. Unterberg, Towbin Emerging Growth Opportunities Conference at the Mandarin Oriental Hotel in New York on Wednesday, July 11th, at 2:30 p.m. ET.

About AtriCure, Inc.

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft and cardiac tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation "AF", a rapid, irregular quivering of the upper chambers of the heart. AF affects more than 2.5 million people in the U.S. and predisposes them to a five fold increased risk of stroke.

The FDA has cleared the AtriCure bipolar ablation system and the Isolator Synergy(TM) Bipolar Ablation System for the ablation, or destruction, of soft tissues in general and non-cardiac related surgical procedures but to date has not cleared or approved the systems for cardiac use or for the treatment of AF. The FDA has cleared the AtriCure Isolator(TM) Transpolar(TM) Pen for the ablation of cardiac tissue and the evaluation of cardiac arrhythmias, but the Isolator(TM) Transpolar(TM) Pen has not been approved for the treatment of AF.

Contacts:
AtriCure, Inc.
Julie A. Piton
Vice President and Chief Financial Officer
[phone]
[e-mail]

SOURCE AtriCure, Inc.

----------------------------------------------

Julie A. Piton
Vice President and Chief Financial Officer of AtriCure
Inc.
[phone]
[e-mail]